Source:http://linkedlifedata.com/resource/pubmed/id/18089800
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
24
|
pubmed:dateCreated |
2007-12-19
|
pubmed:abstractText |
Neuroblastomas are extremely aggressive, although heterogeneous, cancers with a poor prognosis upon metastasis. Some evidence has suggested a correlative silencing of caspase-8 with MYCN amplification in neuroblastoma. A prognostic effect of this silencing, however, has been disputed. We report here hitherto undescribed roles for caspase-8 in the modulation of cell adhesion and subsequent activation of the Erk signaling pathway. Re-expression of caspase-8 in neuroblastoma cells lacking endogenous caspase-8 expression was found to promote cell adhesion to extracellular matrix and to activate adhesion-dependent signaling pathways, such as the Erk kinase cascade. This function of caspase-8 occurred irrespective of its proteolytic activity. Additionally, a pool of caspase-8 was shown to co-localize with the Src tyrosine kinase at the cellular periphery. Furthermore, our studies showed that caspase-8 forms a physical protein complex with Src via its death effector domains (DED) and maintains the complex in a detergent-soluble fraction. We also show that the DEDs of caspase-8 alone are necessary and sufficient to recreate the adhesive and biochemical phenotypes observed with the full-length protein, suggesting that caspase-8 may exert these effects via its association with Src. This protein complex association of caspase-8 and Src, and concomitant downstream signaling events, may help reconcile why a potential tumor suppressor such as caspase-8 is rarely absent in cancers.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1538-7445
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
67
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
11704-11
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18089800-Alstrom Syndrome,
pubmed-meshheading:18089800-Caspase 8,
pubmed-meshheading:18089800-Cell Adhesion,
pubmed-meshheading:18089800-Cell Line,
pubmed-meshheading:18089800-Cell Line, Tumor,
pubmed-meshheading:18089800-Genes, Tumor Suppressor,
pubmed-meshheading:18089800-Humans,
pubmed-meshheading:18089800-Kidney,
pubmed-meshheading:18089800-Neuroblastoma,
pubmed-meshheading:18089800-RNA, Neoplasm,
pubmed-meshheading:18089800-RNA, Small Interfering,
pubmed-meshheading:18089800-Signal Transduction,
pubmed-meshheading:18089800-Transfection,
pubmed-meshheading:18089800-src-Family Kinases
|
pubmed:year |
2007
|
pubmed:articleTitle |
Novel noncatalytic role for caspase-8 in promoting SRC-mediated adhesion and Erk signaling in neuroblastoma cells.
|
pubmed:affiliation |
Cancer Center, Burnham Institute for Medical Research, La Jolla, California 92037, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|